Showing 1661-1670 of 2528 results for "".
- Alma Introduces PixelPeel™ Laser Peel for Minimal-Downtime Skin Renewalhttps://modernaesthetics.com/news/alma-introduces-pixelpeel-laser-peel-for-minimal-downtime-skin-renewal/2476137/Alma has launched PixelPeel™, a new fractional laser peel treatment designed for subtle, controlled skin resurfacing with minimal recovery time. The treatment is compatible with the Alma Pixel™ and Alma Hybrid® platforms and uses the company’s MotionSync™ technology to deliver uniform exfoliation
- ProRx Highlights Role of 503B Outsourcing in Patient-Centered Wellness Carehttps://modernaesthetics.com/news/prorx-highlights-role-503b-outsourcing-patient-centered-wellness-care/2476084/In recognition of National Wellness Month, ProRx, an FDA-registered 503B outsourcing facility, is emphasizing the clinical value of personalized, high-quality compounded therapies in wellness-focused care models. ProRx provides sterile and non-sterile compounded medications for office use
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers
- Report: GLP-1s Dethrone Skincare Shifting Medical Aesthetic Spendhttps://modernaesthetics.com/news/report-glp-1s-dethrone-skincare-shifting-medical-aesthetic-spend/2475902/Weight-loss medications continue to impact the medical aesthetics industry. GLP-1s surpassed skincare as the top consumer spend category, according to a new report from Guidepoint Qsight. Guidepoint Qsight found patients are focusing on the overall wellness journey, prioritizing bundling
- 2025 EYE-CODE Protocol Update Published in Journal of Cosmetic Dermatologyhttps://modernaesthetics.com/news/2025-eye-code-protocol-update-published-in-journal-of-cosmetic-dermatology/2475857/A newly published update to the EYE-CODE Protocol was recently published in the Journal of Cosmetic Dermatology, providing new insights and updates for nonopthalmologists. Accordin
- BOTOX Cosmetic Selects Entrepreneurs for 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-selects-entrepreneurs-for-2025-confidence-project/2475812/Allergan Aesthetics, an AbbVie company, announced the 2025 class of participants in The Confidence Project: Empowering Women Entrepreneurs, a national program led by BOTOX Cosmetic (onabotulinumtoxinA). The initiative is designed to address the confidence gap among women in business and
- Global Botulinum Toxins Market Projected to Reach $15.7 Billion by 2030https://modernaesthetics.com/news/global-botulinum-toxins-market-projected-to-reach-157-billion-by-2030/2475785/The global market for botulinum toxin products is expected to grow from $8.9 billion in 2025 to $15.7 billion by 2030, according to new projections from MarketsandMarkets, representing a compound annual growth rate (CAGR) of 11.7%. This sustained growth is attributed to increased global de
- SkinSpirit Makes Donation to Kerr County Flood Relief Fundhttps://modernaesthetics.com/news/skinspirit-makes-donation-to-kerr-county-flood-relief-fund/2475718/SkinSpirit has donated to the Kerr County Flood Relief Fund as part of their philanthropic arm, SS Gives. “With our large number of Texas-based clinics, we are proud to donate to the Kerr County
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<
- LevEllis Launches Regenerative Serum Featuring Skin-Specific Secretome Technologyhttps://modernaesthetics.com/news/levellis-launches-regenerative-serum-featuring-skin-specific-secretome-technology/2475660/LevEllis, Inc. announced the launch of PROVOQUE™, a physician-dispensed regenerative skincare serum formulated with a proprietary skin-specific secretome. Developed by surgeon and molecular biologist Laura Ellis, MD, the product represents a new approach in medical-grade skincare by delivering a